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Abstract 
Background: Little is known about the effects of blood rheology on the occurrence of acute 
chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia and 
hemoglobin SC disease. Design and methods: To address this issue, steady-state 
hemorheological profiles (blood viscosity, red blood cell deformability, aggregation 
properties) and hematological parameters were assessed in 44 children with sickle cell anemia 
and 49 children with hemoglobin SC disease (8-16 years old), followed since birth. Charts 
were retrospectively reviewed to determine prior acute chest syndrome or vaso-occlusive 
episodes, and rates of these complications were calculated. Results: Multivariate analysis 
revealed that: 1) a higher steady-state blood viscosity was associated with a greater rate of 
vaso-occlusive crises in children with sickle cell anemia, but not in children with hemoglobin 
SC disease; 2) a higher steady-state red blood cell disaggregation threshold was associated 
with previous history of acute chest syndrome in children with hemoglobin SC disease and 
boys with sickle cell anemia. Conclusion: Our results indicate for the first time that the red 
blood cell aggregation properties may play a role in the pathophysiology of acute chest 
syndrome in children with hemoglobin SC disease and boys with sickle cell anemia. In 
addition, whereas greater blood viscosity is associated with greater rate of vaso-occlusive 
crises in children with sickle cell anemia, no association was found in children with 
hemoglobin SC disease, underscoring differences in the etiology of vaso-occlusive crises 
between sickle cell anemia and hemoglobin SC disease.  
 
Key words: sickle cell anemia, hemoglobin SC disease, red blood aggregation, blood 
viscosity, red blood cell deformability 
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Introduction 
Sickle cell disease (SCD) is a severe genetic disease characterized by frequent painful vaso-
occlusive crises (VOC) and acute chest syndrome (ACS), requiring patient hospitalization.
1
 
ACS is a major cause of death in 25% of Jamaican patients with homozygous sickle cell 
anemia (SCA).
1
 The phenotypic expression of SCA varies considerably with age and between 
patients,
2,3
 and both intrinsic and extrinsic factors may be responsible for the different 
phenotypes.
4,5
  
Numerous hemorheological alterations are found in SCA patients.
6,7
 Abnormal hemorheology 
may severely impact blood flow
8
 as increased blood viscosity can raise vascular resistance 
both at the systemic and pulmonary levels.
9
 Blood viscosity is modulated by the hematocrit, 
which can be very low in SCD due to hemolysis, and by the rheological properties of red 
blood cells (RBC), which are markedly altered in SCD by the presence of sickle hemoglobin, 
HbS. In addition, although poorly studied in SCD,
7
 RBC aggregation may modulate blood 
flow in smaller blood vessels because increased RBC aggregation causes an accumulation of 
RBC in the central zone of flow (axial migration), resulting in a cell-poor layer near the vessel 
wall, and leading to decreased hematocrit of marginal blood streams (i.e., plasma skimming).
8
 
In addition, large RBC aggregates increase the resistance to blood flow in smaller vessels if 
they are not disaggregated before entering into the capillary network.
10
 Previous studies in 
adult SCA patients demonstrated that increased blood viscosity
11,12
 and increased RBC 
deformability
13
 are risks factors for VOC. Whether these hemorheological parameters are also 
involved in the pathophysiology of VOC in SCA children is unknown. Moreover, no study 
has focused on the association between blood rheology and ACS in SCA children. 
Interestingly, very few studies have been devoted to hemoglobin SC disease (SCC), which 
has long been considered as a variant of SCA, sharing some of the clinical complications but 
with milder severity and lower frequency.
14
 However, Lionnet et al.
15
 recently reported a 
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prevalence of 36% VOC and 20% ACS in a cohort of SCC patients requiring hospitalization. 
The authors concluded that SCC should be considered as a genuine disease.
15
 Although the 
characterization of blood rheology has been done in adult SCC,
7
 no study has investigated the 
possible contribution of blood viscosity and RBC rheological properties to VOC and ACS in 
children with SCC. 
 
The aim of this study was to identify factors associated with painful VOC and ACS in both 
SCA and SCC children to gain insight into the pathophysiology of these diseases. Therefore, 
we have analyzed and compared the hematological and hemorheological profiles in SCA and 
SCC children according to the occurrence and rate (episodes per patient-year) of these two 
major complications. 
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Design and methods 
 
Patients  
The study took place between January 2010 and January 2011, and included 93 children with 
SCD (44=SCA; 49=SCC) between the ages of 8 and 16 years old. This patient group 
represents 80% of the SCD pediatric cohort in this age range, followed since birth by the 
Sickle Cell Center at the Academic Hospital of Pointe-à-Pitre (Guadeloupe, French West 
Indies). As hydroxyurea therapy may modulate the hematological and blood rheology 
parameters, children followed at the Sickle Cell Center who were treated with hydroxyurea 
for more than 2 weeks were not included in the study. However, two SCA children who had 
started hydroxyurea treatment less than 2 weeks before the time of the study were included. 
All children had been identified by neonatal screening, and diagnosis was made by 
isoelectrofocusing (Multiphor II™ System, GE HEALTH CARE, Buck, UK), citrate agar 
electrophoresis, and cation-exchange high performance liquid chromatography 
(VARIANT™, Bio-Rad Laboratories, Hercules, CA, USA), and was confirmed by DNA 
studies.
16
 Polymerase Chain Reaction (Gap-PCR) was used to detect 6 common -
thalassemia deletions, including -3.7and -4.2alleles and triplication defects of the -globin 
genes.
17,18  
Steady-state was defined as no blood transfusions in the previous three months and absence of 
acute episodes (infection, VOC, ACS, stroke, priapism, acute splenic sequestration) at least 
one month before inclusion into the study. Based on few studies, it seems that 
hemorheological changes occurring in SCD patients during painful VOC normalize between 
5-20 days after the end of crisis.
19,20
  
The hemorheological and hematological parameters were measured in blood, sampled at 
steady-state. Charts were retrospectively reviewed by three physicians to identify all ACS and 
6 
 
VOC episodes from birth to the time of blood sampling. The study was conducted in 
accordance with the guidelines set by the Declaration of Helsinki and was approved by the 
Regional Ethics Committee (CPP Sud/Ouest Outre Mer III, Bordeaux, France, registration 
number: 2009-A00211-56). All children and their parents were informed about the purpose 
and procedures of the study, and gave their written consent.  
 
Rates of painful vaso-occlusion crisis and acute chest syndrome  
An acute event was considered a VOC if the painful episode lasted for more than four hours, 
the patient felt that the pain was typical of that of vaso-occlusion, no other etiology of pain 
could be identified by the physicians, and the patient was admitted to the Accident and 
Emergency Pediatric Department to treat the pain with parenteral opioids (with or without 
non-steroidal anti-inflammatory drugs). ACS, splenic or hepatic sequestration or 
exacerbations of chronic painful conditions such as avascular necrosis or leg ulcer were not 
considered as painful VOC episodes.  
ACS was defined as the appearance of a new infiltrate on chest radiograph, associated with 
one or more clinical symptoms such as chest pain, respiratory distress, fever and cough.
1,21
  
The rates of ACS and VOC were calculated for each child by dividing the total number of 
ACS or painful VOC episodes by the number of patient-years.
12
 Due to the limited number of 
patients with a VOC rate greater than 1 in the SCA (n = 5/44) and SCC groups (n = 3/49), the 
classification according to Platt et al.
12
 could not be used. Therefore, each SCD group was 
divided into tertiles according to the painful VOC rate (i.e. episodes per patient-year). LSCA 
(0.04 ± 0.05 episodes per patient-year) and LSCC (0 ± 0 episodes per patient-year) 
corresponded to SCA and SCC patients with lower VOC rate, ISCA (0.23 ± 0.10 episodes per 
patient-year) and ISCC (0.14 ± 0.05 episodes per patient-year) corresponded to SCA and SCC 
patients with intermediate VOC rate and HSCA (0.99 ± 0.45 episodes per patient-year) and 
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HSCC (0.65 ± 0.48 episodes per patient-year) corresponded to the patients with higher VOC 
rate. For ACS, each SCD group was classified according to whether patients had never 
experienced ACS (ACS rate = 0; NACS-SCA or NACS-SCC) or had undergone an ACS (rate 
> 0; ACS-SCA = 0.24 ± 0.16 episodes per patient-year or ACS-SCC = 0.12 ± 0.08 episodes 
per patient-year).  
Although the constitution of SCA and SCC subgroups was made according to VOC or ACS 
rates, none of the subgroups can be considered as clinically severe because mean VOC and 
ACS rates were not very high. Among the SCA children receiving hydroxyurea who were 
excluded from the analysis, several of them were treated for recurrent VOC and/or ACS and 
thus presented a more severe clinical course of the disease than children untreated with 
hydroxyurea included in the present study. Accordingly, our cohorts of children refer to mild 
to moderate forms of SCA and SCC.  
 
Hematological and hemorheological measurements 
Venipuncture was performed between 8:00 a.m. and 10:00 a.m. and EDTA blood samples 
were immediately used for measurements of hemoglobin concentration (Hb), hematocrit 
(Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), reticulocytes 
(RET), red blood cell (RBC), platelet (PLT) and white blood cell (WBC) counts (Max M-
Retic, Coulter, USA). Serum lactate dehydrogenase (LDH) concentration was determined by 
a standard colorimetric method.  
All hemorheological measurements
22
 were carried out within 4 hours of the venipuncture to 
avoid rheological alterations
23
 and after complete oxygenation of the blood.
22
 We strictly 
followed the guidelines for international standardization in blood rheology 
techniques/measurements and interpretation.
22
 Between 8 and 16 yrs old, hemorheological 
characteristics have been demonstrated to be rather stable in healthy population.
24
 Blood 
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viscosity was determined at native Hct, at 25°C and at a shear rate of 90 s
−1
 using a cone/plate 
viscometer (Brookfield DVII+ with CPE40 spindle, Brookfield Engineering Labs, Natick, 
MA). RBC deformability was determined at 37°C at two shear stresses (3 and 30 Pa) by laser 
diffraction analysis (ecktacytometry), using the Laser-assisted Optical Rotational Cell 
Analyzer (LORCA, RR Mechatronics, Hoorn, The Netherlands). RBC aggregation was 
determined at 37°C via syllectometry, (i.e., laser backscatter versus time, using the LORCA) 
after adjustment of the Hct to 40%, and was reported as the aggregation index (AI), which is 
calculated by the LORCA. The disaggregation threshold (γ), i.e., the minimal shear rate 
needed to prevent aggregation or to break down existing aggregates, was determined using a 
re-iteration procedure.
25
 
 
Statistical analysis 
Results are presented as means ± SD. ANOVA (and Tukey post-hoc test) or unpaired 
Student’s t-test and chi-square test were used for continuous covariates and for categorical 
covariates, respectively, to compare hematological and hemorheological parameters between 
the different groups.  
To identify risk factors associated with painful VOC in SCA and SCC children, we used an 
ordinal multivariate logistic model as the variable, VOC, was defined by three ordered 
categories (low/intermediate/high). To identify factors associated with ACS in SCA and SCC 
children, we used a binary (i.e., presence or absence of ACS) multivariate logistic model. All 
variables at p < 0.2 by univariate analysis were included as covariates in the multivariate 
regression models. Significance level was defined as p < 0.05. Analyses were conducted 
using SPSS (v. 20, IBM SPSS Statistics, Chicago, IL).  
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Results 
Comparisons of hematological and hemorheological profiles, and VOC and ACS rates 
between SCA and SCC children  
The data are reported in Table 1. Gender distribution, prevalence of -thalassemia and age 
were similar between the SCA and SCC groups. As expected, HbF levels, WBC counts, PLT 
counts, MCV, MCH, RET counts and LDH were significantly higher (p<0.001) in SCA than 
in SCC children while RBC counts, Hb and Hct levels were significantly lower (p<0.001) in 
SCA than in SCC children.  
Blood viscosity and RBC deformability at 30 Pa were significantly lower in SCA than in SCC 
children (p < 0.001) while RBC deformability at 3 Pa and  were not significantly different 
between the two groups. SCA children had greater AI than SCC children (p < 0.05).  
Although the painful VOC rate was lower in SCC than in SCA group, the difference did not 
reach statistical significance (p < 0.1). SCA children exhibited greater ACS rates (p < 0.001) 
than SCC children.  
 
Association of the hematological and hemorheological parameters with VOC and ACS rate in 
SCA children 
Table 2 shows the results of the hematological and hemorheological parameters in the SCA 
subgroups categorized according to the VOC rate. No difference was seen in the 
hematological parameters between the three groups, except for the Hb levels that were lower 
in LSCA than in ISCA and HSCA children (p < 0.05), and the Hct which was higher in the 
HSCA group (p < 0.05) compared to LSCA group but not significantly different between 
ISCA and LSCA groups (p < 0.1). LDH and RBC counts showed no difference between the 
three groups but had a p < 0.20 by ANOVA. 
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Blood viscosity and RBC deformability at 30 Pa were greater in HSCA and ISCA children 
than in LSCA children (p < 0.05). In contrast, RBC deformability at 3 Pa was only increased 
in HSCA children (p < 0.05). No difference between the three groups was observed in AI (p < 
0.20) and  In the SCA group, no association was found between the painful VOC rate and 
the ACS rate categories by the chi-square test. 
An ordinal multivariate logistic model was used that included blood viscosity, RBC 
deformability at 30 Pa, AI, LDH levels, and Hb levels as covariates. Hct and RBC counts 
were not included to avoid co-linearity effects with Hb levels. The overall model was 
statistically significant (chi-square = 17.05; df = 5; p < 0.01). However, only blood viscosity 
was significantly associated with the VOC rate categories with an odd ratio of 1.57 (95% CI 
1.14 to 2.17, p < 0.01).  
 
As shown in Table 3, the gender distribution was significantly different between the two 
groups (p < 0.05), with a greater number of boys in the ACS-SCA group. The MCV (p < 
0.01) and MCH values (p < 0.05) were lower in the ACS-SCA group than in the NACS-SCA 
group. All other hematological and hemorheology values were not different between the two 
groups of SCA children. 
AI, -thalassemia frequency and RBC counts, while not different between the two groups, 
had a p value less than 0.2 by unpaired Student’s t-test and therefore were included as 
covariates in a binary multivariate logistic model along with MCV, MCH, and gender. The 
overall model was not statistically significant (chi-square = 11.60; df = 6; p = 0.07). 
Nevertheless, because p values for gender and MCV in the multivariate model were < 0.1, we 
performed new univariate and multivariate analyses after grouping children by gender.  
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In SCA boys, univariate analysis showed no difference between NACS-SCA and ACS-SCA 
children for all the parameters, except for  for which a statistically significant difference was 
detected between the two groups (Table 4, p < 0.01).  
As PLT counts and RET counts reached a p < 0.2 by Student’ t test, they were included as 
covariates in the new binary multivariate logistic model along with . The overall model was 
statistically significant (chi-square = 9.07; df = 3; p < 0.05) and  was the only parameter 
significantly associated with the ACS rate categories in boys with an odd ratio of 1.02 (95% 
CI 1.0 to 1.05; p < 0.05).  
 
For SCA girls, no difference in age, HbF levels, WBC, PLT and RET counts, Hb and Hct 
levels, LDH, RBC deformability at 3 and 30 Pa, AI and  was found between NACS-SCA and 
ACS-SCA groups (Table 5). Blood viscosity and -thalassemia frequency were not 
significantly different between the two groups but reached a p < 0.20 by unpaired Student’s t-
test. MCV and MCH were lower in the ACS-SCA than in the NACS-SCA girls (p < 0.05).  
MCV, MCH, RBC counts, blood viscosity and -thalassemia were used as covariates in a 
binary multivariate logistic model. The overall model was not statistically significant (chi-
square = 7.78; df = 5; p = 0.17) and none of the covariates tested showed significance. 
 
Associations of hematological and hemorheological parameters with VOC and ACS rate in 
SCC children 
As shown in Table 6, none of the parameters tested showed significant difference between the 
three SCC groups. A Chi-square test demonstrated lack of association between the VOC rate 
category and the ACS rate class in the SCC children.  
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Gender and AI, which had a p value of < 0.20 by ANOVA were included in the ordinal 
multivariate logistic model with AI as covariate and gender as factor. The model was not 
statistically significant (chi-square = 0.21; df = 2; p = 0.90). 
 
As shown in Table 7, PLT counts (p < 0.05), blood viscosity (p < 0.05) and  values (p < 
0.05) were significantly higher in ACS-SCC children compared to NACS-SCC children. RBC 
deformability at 30 Pa was lower in the ACS-SCC group compared to the NACS-SCC group 
(p < 0.05).  
The binary multivariate logistic model including PLT counts, blood viscosity, RBC 
deformability at 30 Pa and  was statistically significant (chi-square = 12.02; df = 4; p < 0.05) 
and  was independently associated with the ACS rate category with an odd ratio of 1.01 
(95% CI 1.0 to 1.02, p < 0.05). 
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Discussion 
The present study demonstrates 1) an association between the RBC disaggregation threshold 
and the rate of ACS occurrence in SCC children; 2) no association between any of the 
hemorheological factors and VOC rate in SCC children; 3) an association between increased 
RBC disaggregation threshold and ACS occurrence in SCA boys, but not in SCA girls; 4) an 
association between increased blood viscosity and higher painful VOC rate in children with 
SCA. Until now, no study had investigated the role of hemorheological factors (i.e. blood 
viscosity, RBC deformability and RBC aggregation properties) in the pathophysiology of 
ACS and VOC in the SCC population.  
 
Hemoglobin SC disease has long been considered as a mild form of SCA; however, a recent 
study demonstrated that it is in fact a distinct disease.
15
 They reported a greater prevalence of 
retinopathy and sensorineural otologic disorders in SCC patients than in SCA patients.
15
 The 
authors suggested that these findings could be attributed to the greater blood viscosity 
observed in SCC patients,
15
 as observed in the present study. Lionnet et al.
15
 also showed a 
high prevalence of VOC and ACS in their SCC population.  
SCC children who had previously developed ACS had higher blood viscosity, lower RBC 
deformability and greater RBC disaggregation threshold than SCC children who never 
experienced ACS. Each of these hemorheological parameters may affect the pulmonary 
vasculature. In animal models, increased blood viscosity and reduced RBC deformability 
have been shown to increase pulmonary vascular resistance,
9,26
 and impaired RBC 
aggregation properties were demonstrated to impact microcirculation.
10
 Multivariate analysis 
demonstrated that the RBC disaggregation threshold was the only parameter associated with 
the occurrence of ACS in SCC children. This is the first time that a component of RBC 
aggregation is identified as a risk factor for ACS in the SCC population. Elevated RBC 
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disaggregation is thought to increase flow resistance at the entry of capillaries as RBC 
aggregates need to be completely dispersed before they can enter, and negotiate small 
capillaries.
10
 The reasons of the increased threshold necessary to disaggregate RBC 
aggregates in a subset of SCC children are unknown, but it is probably not related to 
fibrinogen concentration, which is known to be a RBC pro-aggregating agent.
7
 Further studies 
will be needed to understand why RBCs from SCC children with previous history of ACS are 
stickier than RBCs from children who never experienced ACS.  
 
Surprisingly, we could not show that blood viscosity was associated with the VOC rate in 
SCC children. Statistical analyses revealed no significant difference in any of the 
hematological and hemorheological parameters tested between LSCC, ISCC and HSCC 
children. In addition, although SCC children had far greater blood viscosity levels than SCA 
children, the VOC rate was lower in SCC than in SCA children. The determinants of clinical 
severity in SCC patients are still poorly understood
1
, but Mohan et al.
27
 recently demonstrated 
that vascular function is better preserved in SCC patients than in SCA patients. As vascular 
resistance depends on hemorheological factors and vascular function, one may hypothesize 
that the preserved vascular function in SCC children can adjust better to the elevated blood 
viscosity than the vascular function in SCA children. This could account for the decrease in 
VOC occurrence in SCC children. 
 
Our study also demonstrated that SCA children with the greater VOC rate have higher steady-
state Hb levels, Hct, blood viscosity and RBC deformability values than children with the 
lower VOC rate. These findings are highly consistent with those described in SCA adults by 
several authors who observed that higher VOC frequency was associated with higher Hct,
12
 
blood viscosity
11
 and RBC deformability.
13,28
 Ballas et al.
13
 proposed that the more sickle 
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RBC are deformable, the greater their adherence to vascular endothelium will be, and the 
more they may cause VOC. This is in accordance with a previous study where the authors 
demonstrated that irregularly shaped, deformable sickle RBCs were more adherent than rigid, 
irreversibly sickle RBCs.
29
 Nevertheless, multivariate analysis showed that only blood 
viscosity remained associated with the VOC rate categories. The lack of association between 
RBC deformability and VOC categories may be due to the very wide inter-individual 
variability of this parameter, as previously shown by Ballas et al.
13
 Taken altogether, our 
results indicate that blood viscosity may be a useful marker of increased risk of VOC in SCA 
children, as it is in SCA adults.
11
  
 
Castro et al.
30
 previously reported that reduced steady-state Hb and increased HbF levels 
decreased the ACS rate in SCA patients (adults and children together). In the present study, 
we did not find any significant difference in the Hb, Hct or HbF levels between ACS-SCA 
and NACS-SCA children. However, the univariate analysis indicated that gender distribution 
was different between ACS-SCA group and NACS-SCA group, prompting us to analyze the 
data from boys and girls separately. Whereas no hematological or hemorheological 
parameters was associated with ACS in girls, multivariate analysis showed that the RBC 
disaggregation threshold was significantly associated with ACS in boys, as it is in SCC boys 
and girls. This gender-related difference in the SCA population remains unexplained and 
further studies with a larger number of SCA children are needed to address this issue. 
 
In conclusion, this is the first study devoted to the study of the relationship between the full 
hemorheological profile and clinical severity of SCD. The present data demonstrate an 
association between blood viscosity and VOC rate in SCA children, and suggest that the 
presence of RBC aggregates in the circulation could increase the risk for ACS occurrence in 
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SCC children and SCA boys. Future longitudinal studies should be focused on the intra-
patient evolution of hemorheological parameters (i.e. during steady state, VOC or ACS, 
recovery periods) to better define the impact of blood rheology in the pathophysiology of 
these acute complications. 
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Table 1: Demographical, hematological and hemorheological data of SCD children 
 SCA (n = 44) SCC (n = 49) 
Sex ratio (M/F) 23/21 28/21 
alpha-thalassemia (%) 36.4 34.7 
Age (yrs) 11.4 ± 2.4 11.9 ± 2.3 
VOC rate 0.41 ± 0.48 0.26 ± 0.39 
ACS rate 0.12 ± 0.17 0.03 ± 0.06*** 
HbF (%) 8.7 ± 6.5 2.9 ± 2.9*** 
WBC (10
9
/dL) 11.0 ± 2.7 7.3 ± 2.8*** 
RBC (10
12
/dL) 2.9 ± 0.7 4.4 ± 0.5*** 
PLT (10
9
/dL) 454 ± 122 280 ± 135*** 
Hb (g.dl
-1
) 7.9 ± 1.3 11.2 ± 1.0*** 
Hct (%) 23.1 ± 4.2 31.7 ± 2.8*** 
MCV (fl) 80.6 ± 7.8 71.7 ± 5.8*** 
MCH (pg) 27.7 ± 2.0 25.3 ± 2.4*** 
RET (10
9
/dL) 295 ± 115 129 ± 45*** 
LDH (IU) 579 ± 179 299 ± 81*** 
Blood viscosity (mPa.s
-1
) 7.1 ± 2.3 8.5 ± 1.9** 
RBC deformability at 3 Pa (a.u.) 0.16 ± 0.06 0.17 ± 0.03 
RBC deformability at 30 Pa (a.u.) 0.38 ± 0.11 0.45 ± 0.05*** 
AI (%) 49.3 ± 10.4 44.8 ± 8.4* 
 (s-1) 270 ± 93 285 ± 118 
VOC, painful vaso-occlusive crisis; ACS, acute chest syndrome; HbF, foetal hemoglobin; 
WBC, white blood cell count; RBC, red blood cell count; PLT, platelet count; Hb, 
hemoglobin concentration; Hct, hematocrit; MCV, mean cell volume; MCH, mean 
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corpuscular hemoglobin; RET, reticulocytes count; LDH, lactate dehydrogenase; AI, red 
blood cell aggregation index; , red blood cell disaggregation threshold 
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Table 2: Comparison of hematological and hemorheological parameters of SCA children 
classified accordingly to painful VOC rates 
 LSCA (n = 
15) 
ISCA (n = 15) HSCA (n = 14) 
Sex ratio (M/F) 7/8 7/8 9/5 
alpha-thalassemia (%) 33.3% 33.3% 42.9% 
Age (yrs) 11.5 ± 2.5 11.4 ± 2.4 11.1 ± 2.3 
HbF (%) 6.0 ± 2.8 10.7 ± 7.6 8.1 ± 5.9 
WBC (10
9
/dL) 11.5 ± 2.6 10.6 ± 3.2 10.9 ± 2.3 
RBC (10
12
/dL) 2.7 ± 0.6 2.9 ± 0.7 3.2 ± 0.6 
PLT (10
9
/dL) 487 ± 131 440 ± 145 433 ± 79 
Hb (g.dl
-1
) 7.2 ± 1.1 8.1 ± 1.5* 8.4 ± 1.1* 
Hct (%) 21.0 ± 3.5 23.5 ± 4.7 25.1 ± 3.4* 
MCV (fl) 80.0 ± 8.3 81.5 ± 6.8 80.2 ± 8.5 
MCH (pg) 27.7 ± 3.0 28.4 ± 2.8 27.0 ± 3.3 
RET (10
9
/dL) 314 ± 127 261 ± 114 310 ± 104 
LDH
§
 (IU) 658 ± 163 547 ± 174 507 ± 182 
Blood viscosity (mPa.s
-1
)
‡‡
 6.0 ± 1.8 8.0 ± 2.2* 7.5 ± 2.3* 
RBC deformability at 3 Pa (a.u.) 0.14 ± 0.04 0.17 ± 0.08 0.19 ± 0.05* 
RBC deformability at 30 Pa 
(a.u.) 
0.33 ± 0.07 0.40 ± 0.12* 0.42 ± 0.10* 
AI (%)
§
 47.0 ± 8.6 47.7 ± 10.5 53.6 ± 11.3 
 (s-1) 265 ± 92 261 ± 120 284 ± 60 
VOC, painful vaso-occlusive crisis; HbF, foetal hemoglobin; WBC, white blood cell count; 
RBC, red blood cell count; PLT, platelet count; Hb, hemoglobin concentration; Hct, 
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hematocrit; MCV, mean cell volume; MCH, mean corpuscular hemoglobin; RET, 
reticulocytes count; LDH, lactate dehydrogenase; AI, red blood cell aggregation index; , red 
blood cell disaggregation threshold. Statistical difference compared to LSCA children (*p < 
0.05, **p < 0.01, ***p < 0.001), statistical difference compared to ISCA children (
†
p < 0.05, 
††
p < 0.01, 
†††
p < 0,001), 
§
additional parameters included in the multivariate analysis (p < 
0.20), 
‡‡
significant association after the multivariate analysis (p < 0.01). 
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Table 3: Comparison of hematological and hemorheological parameters of SCA children 
classified accordingly to the occurrence of ACS 
 NACS-SCA (n = 22) ACS-SCA (n = 22) 
Sex ratio (M/F) 8/14 15/7* 
alpha-thalassemia (%)
§
 27.3 45.5 
Age (yrs) 10.9 ± 2.4 11.8 ± 2.2 
HbF (%) 9.6 ± 7.2 6.9 ± 3.9 
WBC (10
9
/dL) 11.2 ± 3.0 10.7 ± 2.4 
RBC (10
12
/dL)
§
 2.7 ± 0.4 3.1 ± 0.8 
PLT (10
9
/dL) 473 ± 140 436 ± 100 
Hb (g.dl
-1
) 7.8 ± 1.2 8.0 ± 1.4 
Hct (%) 22.9 ± 3.9 23.4 ± 4.6 
MCV (fl) 83.8 ± 6.5 77.4 ± 7.7** 
MCH (pg) 28.8 ± 2.5 26.6 ± 3.1* 
RET (10
9
/dL) 287 ± 135 302 ± 95 
LDH (IU) 609 ± 193 548 ± 163 
Blood viscosity (mPa.s
-1
) 7.2 ± 2.3 7.1 ± 2.2 
RBC deformability at 3 Pa (a.u.) 0.17 ± 0.07 0.16 ± 0.06 
RBC deformability at 30 Pa (a.u.) 0.39 ± 0.10 0.38 ± 0.12 
AI (%)
§
 48.9 ± 8.7 49.7 ± 12.0 
 (s-1) 266 ± 110 274 ± 74 
ACS, acute chest syndrome; HbF, foetal hemoglobin; WBC, white blood cell count; RBC, red 
blood cell count; PLT, platelet count; Hb, hemoglobin concentration; Hct, hematocrit; MCV, 
mean cell volume; MCH, mean corpuscular hemoglobin; RET, reticulocytes count; LDH, 
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lactate dehydrogenase; AI, red blood cell aggregation index; , red blood cell disaggregation 
threshold. Statistical difference between the two groups (*p < 0.05, **p < 0.01, ***p < 
0.001), 
§
additional parameters included in the multivariate analysis (p < 0.20) 
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Table 4: Comparison of hematological and hemorheological parameters of SCA boys 
classified accordingly to the occurrence of ACS 
 NACS-SCA (n = 8) ACS-SCA (n = 15) 
alpha-thalassemia (%) 25.0 40.0 
Age (yrs) 11.6 ± 2.8 11.7 ± 2.5 
HbF (%) 9.5 ± 8.9 5.8 ± 3.2 
WBC (10
9
/dL) 10.7 ± 1.8 10.2 ± 2.3 
RBC (10
12
/dL) 2.8 ± 0.4 3.1 ± 0.9 
PLT (10
9
/dL)
§
 492 ± 136 415 ± 111 
Hb (g.dl
-1
) 7.3 ± 1.2 7.5 ± 1.6 
Hct (%) 22.1 ± 3.7 22.5 ± 5.0 
MCV (fl) 79.9 ± 7.2 76.3 ± 8.6 
MCH (pg) 27.1 ± 2.7 26.3 ± 3.3 
RET (10
9
/dL)
§
 251 ± 66 315 ± 105 
LDH (IU) 590 ± 168 549 ± 117 
Blood viscosity (mPa.s
-1
) 7.5 ± 2.4 6.4 ± 2.3 
RBC deformability at 3 Pa (a.u.) 0.15 ± 0.06 0.15 ± 0.06 
RBC deformability at 30 Pa (a.u.) 0.39 ± 0.06 0.37 ± 0.12 
AI (%) 45.8 ± 9.7 47.8 ± 12.1 
 (s-1)‡ 200 ± 54 288 ± 66** 
ACS, acute chest syndrome; HbF, foetal hemoglobin; WBC, white blood cell count; RBC, red 
blood cell count; PLT, platelet count; Hb, hemoglobin concentration; Hct, hematocrit; MCV, 
mean cell volume; MCH, mean corpuscular hemoglobin; RET, reticulocytes count; LDH, 
lactate dehydrogenase; AI, red blood cell aggregation index; , red blood cell disaggregation 
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threshold. Statistical difference between the two groups (*p < 0.05, **p < 0.01, ***p < 
0.001), 
§
additional parameters included in the multivariate analysis (p < 0.20), 
‡
significant 
association after the multivariate analysis (p < 0.05). 
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Table 5: Comparison of hematological and hemorheological parameters of SCA girls 
classified accordingly to the occurrence of ACS 
 NACS-SCA (n = 14) ACS-SCA (n = 7) 
alpha-thalassemia (%)
§
 28.6 57.1 
Age (yrs) 10.5 ± 2.2 12.0 ± 1.6 
HbF (%) 11.1 ± 7.9 9.2 ± 4.5 
WBC (10
9
/dL) 11.0 ± 3.4 10.8 ± 1.9 
RBC (10
12
/dL)
§
 2.6 ± 0.5 3.1 ± 0.7 
PLT (10
9
/dL) 461 ± 147 482 ± 53 
Hb (g.dl
-1
) 7.5 ± 1.3 7.7 ± 1.4 
Hct (%) 22.7 ± 4.2 23.4 ± 3.9 
MCV (fl) 85.2 ± 5.6 78.3 ± 5.6* 
MCH (pg) 29.7 ± 1.9 27.3 ± 3.0* 
RET (10
9
/dL) 308 ± 160 274 ± 65 
LDH (IU) 621 ± 214 547 ± 252 
Blood viscosity (mPa.s
-1
)
§
 7.1 ± 2.4 8.4 ± 1.3 
RBC deformability at 3 Pa (a.u.) 0.18 ± 0.07 0.16 ± 0.06 
RBC deformability at 30 Pa (a.u.) 0.40 ± 0.12 0.39 ± 0.11 
AI (%) 50.7 ± 7.8 53.8 ± 11.5 
 (s-1) 293 ± 121 244 ± 86 
ACS, acute chest syndrome; HbF, foetal hemoglobin; WBC, white blood cell count; RBC, red 
blood cell count; PLT, platelet count; Hb, hemoglobin concentration; Hct, hematocrit; MCV, 
mean cell volume; MCH, mean corpuscular hemoglobin; RET, reticulocytes count; LDH, 
lactate dehydrogenase; AI, red blood cell aggregation index; , red blood cell disaggregation 
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threshold. Statistical difference between the two groups (*p < 0.05, **p < 0.01, ***p < 
0.001), 
§
additional parameters included in the multivariate analysis (p < 0.20) 
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Table 6: Comparison of hematological and hemorheological parameters of SCC children 
classified accordingly to painful VOC rates 
 LSCC (n = 17) ISCC (n = 16) HSCC (n = 16) 
Sex ratio (M/F)
§
 7/10 12/4 8/8 
alpha-thalassemia (%) 44.4 40.0 18.8 
Age (yrs) 12.4 ± 2.0 12.1 ± 2.4 11.3 ± 2.3 
HbF (%) 3.6 ± 3.5 2.8 ± 3.5 2.4 ± 1.6 
WBC (10
9
/dL) 7.5 ± 3.1 7.0 ± 2.5 7.3 ± 2.9 
RBC (10
12
/dL) 4.5 ± 0.5 4.5 ± 0.7 4.3 ± 0.5 
PLT (10
9
/dL) 262 ± 113 293 ± 153 288 ± 146 
Hb (g.dl
-1
) 11.1 ± 1.2 11.3 ± 1.0 11.2 ± 0.8 
Hct (%) 31.8 ± 3.1 32.1 ± 3.0 31.2 ± 2.3 
MCV (fl) 71.1 ± 6.3 71.5 ± 6.4 72.6 ± 5.0 
MCH (pg) 24.8 ± 2.5 25.3 ± 2.6 26.0 ± 2.1 
RET (10
9
/dL) 121 ± 44 127 ± 43 139 ± 48 
LDH (IU) 277 ± 90 322 ± 90 301 ± 57 
Blood viscosity (mPa.s
-1
) 8.6 ± 1.8 8.3 ± 2.1 8.6 ± 2.1 
RBC deformability at 3 Pa (a.u.) 0.17 ± 0.03 0.17 ± 0.04 0.18 ± 0.02 
RBC deformability at 30 Pa (a.u.) 0.46 ± 0.05 0.45 ± 0.05 0.45 ± 0.05 
AI (%)
§
 46.7 ± 10.6 41.1 ± 5.4 46.9 ± 5.9 
 (s-1) 305 ± 153 245 ± 72 301 ± 103 
VOC, painful vaso-occlusive crisis; HbF, foetal hemoglobin; WBC, white blood cell count; 
RBC, red blood cell count; PLT, platelet count; Hb, hemoglobin concentration; Hct, 
hematocrit; MCV, mean cell volume; MCH, mean corpuscular hemoglobin; RET, 
reticulocytes count; LDH, lactate dehydrogenase; AI, red blood cell aggregation index; , red 
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blood cell disaggregation threshold. Statistical difference compared to LSCC children (*p < 
0.05, **p < 0.01, ***p < 0.001) 
§
additional parameters included in the multivariate analysis (p 
< 0.20) 
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Table 7: Comparison of hematological and hemorheological parameters of SCC children 
classified accordingly to the occurrence of ACS 
 NACS-SCC (n = 38) ACS-SCC (n = 11) 
Sex ratio (M/F) 20/18 8/3 
alpha-thalassemia (%) 36.8 27.3 
Age (yrs) 11.9 ± 2.3 12.1 ± 2.2 
HbF (%) 3.1 ± 3.3 2.3 ± 1.6 
WBC (10
9
/dL) 7.1 ± 3.0 7.9 ± 2.1 
RBC (10
12
/dL) 4.5 ± 0.5 4.3 ± 0.6 
PLT (10
9
/dL) 256 ± 121 360 ± 152* 
Hb (g.dl
-1
) 11.2 ± 1.0 11.0 ± 0.9 
Hct (%) 31.9 ± 2.8 31.1 ± 2.8 
MCV (fl) 71.3 ± 5.6 73.1 ± 6.7 
MCH (pg) 25.2 ± 2.3 25.9 ± 2.6 
RET (10
9
/dL) 127 ± 44 137 ± 49 
LDH (IU) 288 ± 71 330 ± 105 
Blood viscosity (mPa.s
-1
) 8.2 ± 1.9 9.7 ± 1.7* 
RBC deformability at 3 Pa (a.u.) 0.18 ± 0.03 0.17 ± 0.03 
RBC deformability at 30 Pa (a.u.) 0.46 ± 0.04 0.42 ± 0.05* 
AI (%) 44.4 ± 7.9 47.6 ± 9.0 
 (s-1)‡ 266 ± 83 350 ± 188* 
ACS, acute chest syndrome; HbF, foetal hemoglobin; WBC, white blood cell count; RBC, red 
blood cell count; PLT, platelet count; Hb, hemoglobin concentration; Hct, hematocrit; MCV, 
mean cell volume; MCH, mean corpuscular hemoglobin; RET, reticulocytes count; LDH, 
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lactate dehydrogenase; AI, red blood cell aggregation index; , red blood cell disaggregation 
threshold. Statistical difference between the two groups (*p < 0.05, **p < 0.01, ***p < 
0.001), 
§
additional parameters included in the multivariate analysis (p < 0.20), 
‡
significant 
association after the multivariate analysis (p < 0.05). 
 
